Supportive Care in Cancer
|
|
- Clare Allen
- 6 years ago
- Views:
Transcription
1 Supportive Care in Cancer
2 in Cancer Springer-Verlag /s Original Article The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care Digant Gupta 1, Christopher G. Lis 1, Timothy C. Birdsall 1 and James F. Grutsch 1 (1) Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center, Zion, IL, USA Authors Contact: Digant Gupta digant.gupta@mrmc-ctca.com Phone: Fax: Supportive Care in Cancer, Volume 13, Issue 11, Nov 2005, Pages Received: 4 January 2005 Accepted: 7 April 2005 Published online: 23 April 2005 Abstract Goals of work There is little data on the prevalence of use of dietary supplements in cancer, especially in light of the growing evidence that some dietary supplements can have adverse interactions with conventional cancer treatment. The purpose of this study was to investigate the use of dietary supplements among adult cancer patients in a community hospital comprehensive cancer center. Patients and methods A survey of 227 new adult cancer patients presenting for treatment for the first time at Cancer Treatment Centers of America at Midwestern Regional Medical Center, between November 2001 and October Patients completed the McCune Questionnaire, a validated instrument that captures information on the use of 56 dietary supplements in cancer, at admission to the hospital. Results Of the 227 patients, 73% used some form of dietary supplements during the 30 day period before the survey was conducted. Dietary supplement use was significantly higher (p = 0.04) in patients with colorectal (80%) and breast (75%) cancer as compared to patients with lung cancer (53%). Patients with stage II (86%) and III (76%) disease at diagnosis were more likely (p = 0.02) to use dietary supplements as compared to those with stage I (71%) disease at diagnosis, while those with stage IV (61%) disease at diagnosis were least likely to use them. Of the 80 patients who had received chemotherapy within the last 30 days, 71% had also used dietary supplements in that timeframe and 25% had consumed one or more herbal therapies that are suspected to
3 have adverse interactions with chemotherapy. Of the 57 patients combining chemotherapy with dietary supplements, 52.6% did not consult a healthcare professional. Conclusions In our study, twenty-five percent of patients receiving chemotherapy were concurrently using dietary supplements suspected to have adverse interactions with chemotherapy, usually relying on information sources other than healthcare professionals. Given the prevalence rates of these agents, healthcare providers should systematically inquire about them, and consider the potential for drug-dietary supplement interactions in treatment planning. Keywords Dietary supplements - Cancer - Chemotherapy - Interaction Introduction The use of complementary and alternative medicine (CAM) in the USA continues to attract an increasing level of attention from the medical community and the public [1, 2]. Dietary supplements, which include vitamins, minerals, and herbs, are among the most commonly used CAM therapies. With a larger number of the US population using dietary supplements combined with allopathic treatments, the risk for dietary supplement drug interaction is a growing concern [ 3 5]. This risk becomes greater for cancer patients re ceiving chemotherapy agents, as these agents have a narrow therapeutic index [6]. In fact, a few herbal therapies such as garlic, ginkgo, Echinacea, ginseng, valerian, kava, grapeseed, soy, and St.-John s-wort have been identified to have potentially adverse interact ions with some co mmonly used chemotherapy ag ents [4]. Consequently, the possibility of unrecogniz ed herb drug interactions is emerging as a significant concern for treating oncologists. Although several studies have reported on the utilization of dietary supplements as part of an overall assessment of C AM use [7 18], only a few studies published to date have reported exclusively on dietary supple ment use in a cancer treatment setting [6, 19]. The purpose of this study was to investigate the use of dietary supplements in a community hospital comprehensive cancer center examining the ( 1) prevalence and patterns of use, (2) characteristics of users, (3) reasons and information sources of use, and (4) perceived benefits of use. Patients and methods Patient population The study was conducted on a convenience sample of new cancer patients who presented for the first time to Cancer Treatment Centers of America at Midwestern Regional Medical Center, Zion, IL, between November 2001 and October Criteria for entry into the study included a minimum age of 18 years, diagnosis of any type of cancer, a life expectancy of at least 2 months, and literacy in the English language. Patients with any tumor type and stage of the disease at diagnosis were eligible for the study. Patients were
4 excluded if they were unable to give informed consent or understand or cooperate with study conditions. A trained clinical coordinator described the study and determined eligibility after patients signed in at the clinic. As part of the consent process, patients were assured that refusal to participate in the study would not affect their future care in any way. The study was approved by the Institutional Review Board at Midwestern Regional Medical Center. Questionnaire A self-administered questionnaire developed and validated at the University of Washington School of Pharmacy, which captures information on the use of 56 dietary supplements (Table 1) within the preceding 30 days, was used. Space was allowed to indicate any other dietary supplement use that was not included in the questionnaire. This questionnaire collected data on the dose and frequency of dietary supplement use and the specific agents used by the patient. It also gathered relevant demographic and clinical data, such as age, gender, ethnicity, education, family income, and treatment history. In addition, the questionnaire obtained information on the types of providers most often sought for CAM consultations and rationale for dietary supplement use along with their perceived benefits. Patients recorded their own responses directly onto the questionnaire, which was returned to the clinical coordinator within 24 h. Table 1 Dietary supplements listed in the questionnaire 714-X Evening primrose Milk thistle Algae Garlic Multiple vitamin Antineoplastons Geniposide Mushroom Beta carotene Germander Pokeroot Black Cohosh Ginger Pycnogenol Bovine cartilage Ginkgo biloba Quercetin Cancell Ginseng Sassafras Cell forte/ip6 Glucosamine Saw palmetto Chamomile L-Glutamine Selenium Chlorophyll Goldenseal Shark cartilage CoEnzyme Q10 Green Tea Extract St.-John s-wort Coltsfoot Hydrazine sulfate Valerian Comfrey Iscador/mistletoe Vitamin A Creatine Jin Bu Huan Vitamin B6 DHEA Kava Kava Vitamin B12 Dong Quai Kelp Vitamin C Echinacea Licorice root extract Vitamin E EPA (fish oil) Melatonin Zinc
5 Ephedra MGN-3 Statistical analyses All data were analyzed using SPSS 11.5 (SPSS Inc., Chicago, IL, USA). Dietary supplement users were defined as those who had used at least one dietary supplement in the past 1 month. Prevalence, types, reasons, information sources, and perceived benefits of using dietary supplements were described as percentages. Differences between dietary supplement users and nonusers with respect to demographic and clinical characteristics were evaluated using bivariate chi-square test and t-test for independent means depending upon the underlying distribution of the variables. Logistic regression was used to determine factors predicting dietary supplement use in the last 30 days. The dependent variable (use/nonuse of dietary supplements in the past month) was dichotomous. Independent variables included in logistic regression w ere age, gender, ethnicity, education, income, tumor type, prior treatment history, and chemotherapy use in the last 30 days. All analyses were conducted for overall dietary supplement use and dietary supplement use excluding vitamins. The significance level for all analyses was set at alpha = 0.05, and all tests were two-sided. Results Characteristics of respondents A total of 242 cancer patients were approached in the clinic between November 2001 and October 2003 and were screened for eligibility by the clinical study coordinator. All 242 patients were found to be eligible for participation. Of 242 eligible patients, 227 consented to participate and completed the survey. The final study sample consisted of 227 patients with a respon se rate of 93.8%. Table 2 describes the baseline characteristics of our patient cohort in greater detail. Table 2 Baseline characteristics (N=227) Characteristic Categories Percent Gender Male 40.1 Female 59.9 Did not complete high school 5.7 Education High school 40.1 College or trade school 38.3 Graduate or professional 13.2 Unknown 2.6 Caucasian 91.2 Ethnicity African-American 6.2 Others 2.2 Unknown 0.4
6 Characteristic Categories Percent <$20, $20,000 34, Annual household income $35,000 49, $50,000 64, >$65, Unknown 16.7 Progressive disease 57.3 Prior treatment history Newly diagnosed 28.6 Unknown 14.1 Breast 30.0 Colorectal 17.6 Lung 14.1 Diagnosis Pancreatic 4 Prostate 4 Esophagus 4 Others 23.7 Unknown 2.6 I 12.3 II 21.6 Tumor stage at diagnosis III 18.5 IV 30.4 Unknown 17.2 Yes 35.2 Chemotherapy in last 30 days No 60.8 Unknown 4.0 Dietary suppleme nt use in th e last 30 days Users 73.1 Nonusers 26.9 Dietary supplements use excluding vitamins in the Users 63.9 last 30 days Nonusers 36.1 Prevalence and patterns of dietary supplement use Overall, 166 (73.1%) patients had used at lea st one type of dietary supplement during the last 30 days with the median number of therapies being 6 (range 1 45). When vitamins were excluded, 145 (63.9%) patients had used at least one dietary supplement during the last 30 days with the median number of therapies being 4 (range 1 39). The prevalence of
7 use of overall dietary supplements and their use excluding vitamins in patients who had received chemotherapy in the last 30 days was 71.3% (57/80) and 65% (52/80), respectively. Table 3 describes the number of dietary supplements used by our patients. The ten most commonly used dietary supplements are described in Table 4. The five most commo nly used dietary supplements not included in the questionnaire were calcium (8.8%), magnesium (2.6%), folic a cid (2.2%), Essiac tea (1.8%), and iron (1.8%). Table 5 lists the prevalence of use of herbal remedies suspected to have adverse interactions with conventional cancer treatment [4]. The overall prevalence of use of those therapies was 29.5% ( 67/227) with the median number of therapies being 1 (range 1 7), whereas their prevalence of use in patients receiving chemotherapy in the last 30 days was 25% (20/80) with the median number of therapies being 1 (range 1 4). Table 3 Number of dietary supplements used (N=227) Number of dietary All dietary supplements Dietary supplements excluding supplem ents used (% pat ients) vitamins (% patients) More than Table 4 The ten most commonly used dietary supplements (N=227) All dietary supplements Dietary supplements excluding vitamins Therapy Percentage of patients (%) Therapy Percentage of patients (%) Vitamin C 47.1 CoEnzyme Q Multiple vitamin 46.3 Selenium 22.0 Vitamin E 42.3 EPA (fish oil) 19.8 CoEnzyme Q Garlic 18.1 Selenium 22.0 Zinc 17.2 Beta carotene 22.0 Gr een tea extract 16.7
8 All dietary supplements Therapy Percentage of patients (%) Dietary supplements excluding vitamins Percentage of patients Therapy (%) Vitamin B Milk thistle 12.3 Vitamin B Melatonin 10.6 EPA (fish oil) 19.8 Echinacea 9. 7 Garlic 18.1 Cell forte 7.1 Table 5 Prevalence of use of herbal remedies suspected to have adverse interactions with conventional cancer treatment Therapy All patients (N= 227) (% Chemotherapy in last 30 days (N=80) patients ) (% patients) Garlic Echinacea Ginseng Ginkgo Valerian St.-John s-wort Kava Grape seed extract Soy Characteristics associated with dietary supplement use Using bivariate chi-square analysis, statistically significant differences were noted between dietary supplement u sers and non users with re gard to education, tumor typ e, and tumor stage at diagno sis. Increasing dietary supplement use was seen with higher education. Patients with colorectal and breast cancer were more likely to use dietary supplements as compared to patients with lung cancer. Patients with stages II and III disease at diagnosis were more likely to use dietary supplements as compared to those with stage I disease at diagnosis, whereas those with stage IV disease at diagnosis were least likely to use them. Altho ugh statistically nonsignificant, a t rend of incr easing d ietary supplement use with higher annual income was also observed. A detailed description of differences between dietary supplement users and nonusers with respect to demographic and cl inical variables is shown in Table 6. Table 6 Predictors of dietary supplement use Variable All dietary supplem ents Dietary supplements excluding vita mins
9 Users Nonusers χ 2 p Users Nonusers χ Value p Value Gender Males Females Mean age at diagnosis (std. dev.) (10. 1) (10.8) (9.9) 49.4 (10.9) 0.46 Education Did not complete high school High school College or trade school Graduate or professional Ethnicity Caucasian African-American Asian-American Indian Others Annual household income <$20, $20,000 34, $35,000 49, $50,000 64, >$65, Prior treatment history Progressive disease Newly diagnosed Chemotherapy in last 30 days Yes No , Diagnosis Breast Colorectal
10 Dietary supplements excluding All dietary supplements vitamins Variable p Users Nonusers χ 2 se sers χ Value U rs Nonu 2 p Value Lung Tumor stage at diagnosis I II III IV Logistic regression analysis found the following varia bles to be statistically significantly associated with a more frequent dietary supplement use: graduate or professional education (OR=5.57; 95% CI ) and college or trade school (OR=3.53; 95% CI ) with less than high school as reference; colorectal (OR=3.53; 95% CI ) and breast cancer (OR=2.65; 95% CI ) with lung cancer as reference; and stage II (OR=2.4; 95% CI ) and stage III (OR=1.28; 95% CI ) disease at diagnosis with stage I disease at diagnosis as reference. Table 7 describes these associations in greater details. Table 7 Predictors of dietary supplement use in univariate logistic regression model (N=227) Dietary supplements excluding All dietary supplements vitamins Variable OR 95% CI p Value OR 95% CI p Value Education Did not finish high school a 1 1 High school 1.74 College or trade school 3.53 Graduate or professional Tumor site 5.57 (0.54, 5.64) (1.05, 11.86) (1.22, 25.36) (0.34, 3.51) (0.62, 6.56) (1.00, 18.32) 0.05 Lung a 1 1 Colorectal 3.53 (1.25, 9.99) (1.27, 9.07) 0.02 Breast 2.65 (1.09, (1.38, 7.97) 0.01
11 Variable All dietary supplements Dietary supplements excluding vitamins p OR 95% CI Value OR 95% CI p Value Other 2.78 Tumor stage at diagnosis 6.41) (1.19, 6.49) Stage I a (0.88, 4.55) 0.10 Stage II 2.4 (0.76, 7.5) (0.76, 6.1) 0.14 Stage III 1.2 (0.4, 3.8) (0.4, 2.7) 1.0 Stage IV 0.6 (0.2, 1.6) (0.2, 1.4) 0.22 a Reference category Reasons and information sources of dietary supplement use Patients were asked to supply reasons for dietary supplement use from a list of six predefined reasons in the questionnaire. Each patient selected one or more reasons. One hundred thirty-five (59.5%) patients cited that they used dietary supplements to improve the immune system, 123 (54.2%) to do everything possible, 90 (39.6%) to slow the progression of cancer, 72 (31.7%) to use a more holistic approach, 61 (26.9%) to tolerate chemotherapy, and 19 (8.4%) to use psychological forces. Finally, 24 (10.6%) patients cited numerous other reasons, the most common being to improve general health and well being. Additionally, patients were asked to provide their primary sources of information on dietary supplements. Ninety-two (40.5%) patients obtained information from a health food/nutrition store, 84 (37%) from a friend or relative, 64 (28.2%) from a naturopath, 46 (20.3%) from the Internet, 34 (15%) from newspaper or magazine, 18 (7.9%) from an oncologist, and 17 (7.5%) from television. Finally, 54 (23.8%) patients named a source not included in the choices on the questionnaire, the most common information sources being chiropractor, nutritionist, and pharmacist. Perceived benefits of dietary supplement use Patients were asked to rate the perceived benefits of each dietary supplement used on a scale ranging from 0 to 3 ( don t know, not beneficial at all, somewhat beneficial, and extremely beneficial, respectively). Because most patients used more than one dietary supplement, the perceived benefits varied with each individual therapy. As a result, all responses to the question on perceived benefits for all dietary supplements were combined to derive the overall estimates for perceived benefits. Out of a total of 951 responses, 437 (45.9%) were don t know, 242 (25.4%) extremely beneficial, 237 (24.9%) somewhat beneficial, and 35 (3.7%) not beneficial at all. Overall, a total of
12 96 (42.3%) patients responded don t know, as regards to the perceived benefits of one or more dietary supplements, 58 (25.6%) extremely beneficial, 72 (31.7%) somewhat beneficial, and 14 (6.2%) not beneficial at all. Discussion The purpose of this study was to determine the prevalence and patterns, characteristics, reasons, information sources, and perceived benefits of dietary supplement use in cancer patients at a community hospital comprehensive cancer center. There was a high overall prevalence of dietary supplement use in our patient cohort. One hundred sixty-six (73.1%) patients used at least one dietary supplement within the last 30 days, and when vitamins were excluded, the number of patients using at least one dietary supplement was 145 (63.9%). Comparing the overall prevalence rates across different studies is a significant challenge as studies differ on patient population, survey instrument, sample size, response rate, and definition of CAM. Notwithstanding these limitations, the overall prevalence of dietary supplement use in our study is somewhat higher than that reported by Richardson et al. [16] who found an overall dietary supplement use of 62.6% in a wide variety of cancer patients attending a comprehensive cancer treatment center. On the other hand, a recent study conducted by McCune et al. in 76 cancer patients receiving chemotherapy at a university-based outpatient clinic reported the overall prevalence of dietary supplement use to be 78%. Previous studies have identified numerous predictors of CAM use in cancer, the most common being certain demographic characteristics such as younger age [ 9, 11, 13, 15, 16, 18], female gender [13, 16], higher educational [9, 13, 15, 18], and income levels [9, 11 13, 18]. In our study, we did not find any statistically significant associations between dietary supplement use and age, gender, ethnicity, income, and prior treatment history. However, there was an increasing dietary supplement use with higher education. Although not statistically significant, our study found a trend of increasing dietary supplement use with higher incomes. In addition, we found that colorectal and breast cancer patients were more likely to use dietary supplements compared to lung cancer patients. Patients with stages II and III disease at diagnosis were more likely to use dietary supplements as compared to those with stage I disease at diagnosis, whereas those with stage IV disease at diagnosis were least likely to use them. One potential explanation for a relatively lower use of dietary supplements in patients with stage IV disease could be our clinical observation that these patients have difficulty swallowing the dietary supplements. Although there was no statistically significant association between prior chemotherapy and dietary supplement use, 71.3% (57/80) of patients receiving chemotherapy within the last 30 days also used dietary supplements during that same timeframe, and 65% (52/80) used dietary supplements excluding vitamins. Of the 57 patients who indicated both chemotherapy treatment and dietary supplement use within the last 30 days, 30 (52.6%) did not consult a healthcare professional (oncologists, naturopaths, chiropractors, nutritionists, and pharmacists). This finding has important implications for potential
13 herb drug interactions. The recently published review article by Sparreboom et al. [4] reported the existing data on known or suspected interactions between the most commonly used herbal therapies and conventional chemotherapeutic treatment for cancer. The following herbal therapies were identified as having potential adverse pharmacokinetic interactions with oncology drugs: garlic, ginkgo, Echinacea, ginseng, valerian, kava, grapeseed, soy, and St.-John s-wort. In our study, 25% (20/80) of the patients receiving chemotherapy in the last 30 days consumed one or more of these herbal therapies. These findings confirm the need for better patient physician communication on the use of dietary supplements during cancer treatment. In addition, comprehensive research strategies are urgently needed to more accurately establish the nature and extent of interactions between dietary supplements and oncology drugs. Our study has several strengths. A high response rate of 93.8% minimizes response bias, a significant problem in CAM survey research. The questionnaire used in this study evaluated dietary supplement use restricted to the preceding 30 days only, thereby minimizing recall bias. Also, the questionnaire focused on a broad range of dietary supplements, some of which have been identified as having potential adverse interactions with conventional chemotherapy. However, several limitations of this study must be acknowledged. The patient cohort was limited to only those patients who were English speakers and consisted largely of Caucasians with breast cancer. This study sample, therefore, is not broadly representative of cancer patients in general. Our hospital offers a wide range of integrative cancer treatment options including nutritional, naturopathic, mind body medicine, and spiritual therapies in conjunction with conventional cancer care. It seems likely that many patients seeking care at our hospital have a particular interest in pursuing complementary therapies and may therefore have a higher prevalence of dietary supplement use than the broader population of patients with cancer. There was no attempt to systematically evaluate any differences between the respondents and nonrespondents in this study because the identity of the nonrespondents was unknown to the researchers. Although our study describes the prevalence of use of potentially harmful herbal agents in patients receiving chemotherapy in the last 30 days, we did not have any specific information on the chemotherapy treatments used. This information would have enabled us to more extensively evaluate the potential for herb chemotherapy interactions. Due to missing data on tumor stage for 39 patients, the association of tumor stage with dietary supplement use was based on a sample size of 188 only. Our sample size might not have been large enough to accommodate the number of post hoc subgroup comparisons made within this study. Finally, this study was not an attempt to scientifically evaluate the impact of dietary supplements on cancer but rather to describe what proportion of people with cancer use dietary supplements. In summary, a great majority of patients seeking cancer treatment at our institution use dietary supplements. There is increasing dietary supplement use with higher education. Patients with colorectal and breast cancer are more likely to use dietary supplements than patients with lung cancer, and patients with stages II and III disease at diagnosis are more likely to use dietary supplements than patients with stage I disease at diagnosis. Twenty- five percent of patients receiving chemotherapy are concurrently using dietary sup plements suspected to have adverse interactions with chemotherapy, usually relying
14 on information sources other than healthcare professionals. Given the prevalence rates of these agents, healthcare providers should systematically inquire about them and consider the potential for drug dietary supplement interactions in treatment planning. Acknowledgements We thank Thom Wodek for his contributions in the coordination an d daily operation of the study. We also thank Ashmer Aslam for his assistance with dat a acquisition, database management, and data analysis. Dr. Gupta and Dr. Grutsch had full access to all the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis. This study was funded by Cancer Treatment Centers of America (CTCA). Design and conduct of the study; collection, management, analysis, and interpretation of the data; and prep aration, review, or approval of the manuscript were conducted by the authors of this study, who take responsibility for its content. References 1. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL (1993) Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328: Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M et al (1998) Trends in alternative medicine use in the United States, : results of a follow-up national survey. JAMA 280: Markman M (2002) Safety issues in using complementary and alternative medicine. J Clin Oncol 20:39S 41S 4. Sparreboom A, Cox MC, Acharya MR, Figg WD (2004) Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 22: Fugh-Berman A (2000) Herb drug interactions. Lancet 355: McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK (2004) Potential of chemotherapy herb interactions in adult cancer patients. Support Care Cancer 12: Ashikaga T, Bosompra K, O Brien P, Nelson L (2002) Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer 10:
15 8. Boon H, Westlake K, Stewart M, Gray R, Fleshner N, Gavin A et al (2003) Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology 62: Burstein HJ, Gelber S, Guadagnoli E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340: Chrystal K, Allan S, Forgeson G, Isaacs R (2003) The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. N Z Med J 116:U Cui Y, Shu XO, Gao Y, Wen W, Ruan ZX, Jin F et al (2004) Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat 85: DiGianni LM, Garber JE, Winer EP (2002) Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 20:34S 38S 13. Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA et al (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 309: Nam RK, Fleshner N, Rakovitch E, Klotz L, Trachtenberg J, Choo R et al (1999) Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis. J Urol 161: Paltiel O, Avitzour M, Peretz T, Cherny N, Kaduri L, Pfeffer RM et al (2001) Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol 19: Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18: Shen J, Andersen R, Albert PS, Wenger N, Glaspy J, Cole M et al (2002) Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med 2:8
16 18. Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB et al (2000) Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol 18: Oneschuk D, Fennell L, Hanson J, Bruera E (1998) The use of complementary medications by cancer patients attending an outpatient pain and symptom clinic. J Palliat Care 14:21 26
A Survey on Knowledge, Attitudes and Usage of Complementary and Alternative Medicine in Singapore by Hwee-Ling Koh, Hui-Ling Ng & Hsiao-Huei Teo
A Survey on Knowledge, Attitudes and Usage of Complementary and Alternative Medicine in Singapore by Hwee-Ling Koh, Hui-Ling Ng & Hsiao-Huei Teo Introduction Complementary and Alternative Medicine (CAM)
More informationINTEGRATIVE ONCOLOGY
INTEGRATIVE ONCOLOGY Shauna Birdsall, ND, FABNO Director of Naturopathic Medicine and Integrative Oncology Cancer Treatment Centers of America Learning Objectives: Describe Integrative Oncology. Discuss
More informationComplementary and alternative medicine (CAM): communicating with patients A fact sheet for health professionals
Unfortunately, there are people who falsely promote and provide unethical, fraudulent and potentially dangerous treatments for cancer. This fact sheet has been written to provide health professionals with
More informationGeneva Briggs, Pharm.D., BCPS MedOutcomes, Inc.
Geneva Briggs, Pharm.D., BCPS MedOutcomes, Inc. Objectives Discuss the alternative medications that are most dangerous. Identify the most common drug interactions with alternative medications. List five
More informationNutraStock PRODUCT LIST. Softgels + Tablets + Capsules
NutraStock PRODUCT LIST Softgels + Tablets + Capsules JD3000 ACAI 1000 MG & GREEN TEA 500 MG SOFTGEL 8,000 JD3005 ACAI 1500 MG SOFTGEL 8,000 JD3010 ACAI 500 MG SOFTGEL 10,000 JD3015 ALOE VERA GEL 5000
More informationIntegrative Medicine Use in Advanced Cancer
Integrative Medicine Use in Advanced Cancer Gary Asher, MD, MPH Department of Family Medicine Lineberger Comprehensive Cancer Support Program gasher@med.unc.edu Objec&ves Defini&ons CAM, actual prac&ces,
More informationDietary supplement use in cancer patients: is there a link to psychosocial wellbeing?
Dietary supplement use in cancer patients: is there a link to psychosocial wellbeing? Kathryn Taylor Clinical Psychologist St George s Cancer Care Centre St George s Cancer Care Centre Dietary supplements
More informationCustomer #: Purchase Order # (if necessary): HOW WOULD YOU LIKE YOUR ORDER TO BE SHIPPED?
Pharmacy/Clinc Name: Purchase Order # (if necessary): Phone #: Fax #: HOW WOULD YOU LIKE YOUR ORDER TO BE SHIPPED? Ground Standard 4 Days or Less Will Call HOW WOULD YOU LIKE YOUR FAX ORDER TO BE CONFIRMED?
More informationHerbal Product Education in United States Pharmacy Schools: Core or Elective Program?
Articles Herbal Product Education in United States Pharmacy Schools: Core or Elective Program? Elaine D. Mackowiak and Ami Parikh School of Pharmacy, Temple University, 3307 North Broad Street, Philadelph
More informationCancer Facts. Complementary and Alternative Medicine. Complementary and Alternative Medicine in Cancer Treatment: Questions and Answers.
Cancer Facts Complementary and Alternative Medicine Complementary and Alternative Medicine in Cancer Treatment: Questions and Answers Key Points Complementary and alternative medicine (CAM) is a group
More informationC.A.M. Use of HIV/AIDS Patients in the Largest Mexican American Border Region
C.A.M. Use of HIV/AIDS Patients in the Largest Mexican American Border Region Jaime P. Anaya, Pharm.D. 1, José O. Rivera, Pharm.D. 1, Jose Cruz Rodriguez, CPhT. 1, Armando Meza, MD 2. 1 UTEP/UT-AustinCooperative
More informationNatural Health Products (NHP) Use During Cancer Therapy
Natural Health Products (NHP) Use During Cancer Therapy Shirin Abadi BSc(Pharm), ACPR, PharmD, DPLA, MBA, FCSHP, RPh November 2017 I have no real or potential conflicts to disclose! LEARNING OBJECTIVES
More informationPharmasave Nature's Own, Cenovis & Bio-Organics 2 Bay 900mm Planogram - June 2015
Pharmasave Nature's Own, Cenovis & Bio-Organics 2 Bay STRESS & ANXIETY DIGESTION & DETOX ENERGY & PERFORMANCE SLEEP MANAGEMENT MULTIVITAMIN MULTIVITAMINS MEN'S HEART & CIRCULATION MULTIVITAMINS GENERAL
More informationDIN / NPN. Allowable Product Claim* Activity Form. Vitamin A Products. Vitamin B Products. Vitamin C Products
Beta-Carotene TAB.900033-U 80006241 Source of vitamin A to help maintain eyesight, skin, membranes and immune function; and to help in the development and maintenance of night vision, bones, and teeth
More informationCAM Dr Monem Alshok
CAM 31. 3. 2016 Dr Monem Alshok CAM CAM is a group of diverse medical and health care systems, practices, and products that are not presently considered to be part of conventional medicine. Complementary
More informationDietary Suppletnents and Functional Foods
Dietary Suppletnents and Functional Foods Second Edition Geoffrey P. Webb Senior Lecturer in Nutrition and Physiology University of East London School of Health and Bioscience ~WILEY-BLACKWELL A rohn Wiley
More informationThe Use of Complementary and Alternative Medicine in Australia Charlie Changli Xue, Lin Zhang, Vivian Lin and David F. Story
The Use of Complementary and Alternative Medicine in Australia Charlie Changli Xue, Lin Zhang, Vivian Lin and David F. Story Despite apparent high usage of complementary and alterative medicine (CAM) and
More informationBeauty Support. Brain Health Hair, Skin, and Nail Support (Silica complex) 3/90 CT Tablets
Beauty Support 971222 Hair, Skin, and Nail Support (Silica complex) 3/90 CT Tablets Brain Health 971138 Ginkgo Biloba 60mg 3/60 CT Veg Caps 971021 Ginkgo Biloba Plus 3/60 CT Veg Caps 971153 Lecithin 1200mg
More informationChapter 11. Major Characteristics of CAM. Research. CAM Healing Methods. Complementary and Alternative Medicine (CAM) CAM Healing Methods (continued)
Chapter 11 Herbal and Alternative Therapies Complementary and Alternative Medicine (CAM) Considered outside mainstream health care Upper Saddle River, New Jersey 07458 All rights reserved. Major Characteristics
More informationDietary Supplement Use and Beliefs among College Students Enrolled in an Introductory Nutrition Course
University of Tennessee, Knoxville Trace: Tennessee Research and Creative Exchange Masters Theses Graduate School 8-2009 Dietary Supplement Use and Beliefs among College Students Enrolled in an Introductory
More informationHow Your Supplements Interact With Prescription Drugs
How Your Supplements Interact With Prescription Drugs St. John s Wort, lavender, garlic and others can alter drug potency, cause side effects Millions of people consume supplements that may impact the
More informationComplementary and Alternative Medicine Use in Individuals Presenting for Care at a Comprehensive Cancer Center
660384ICTXXX10.1177/1534735416660384Integrative Cancer TherapiesJudson et al research-article2016 Research Article Complementary and Alternative Medicine Use in Individuals Presenting for Care at a Comprehensive
More informationUse of Complementary and Alternative Medicines by Ambulatory Patients
ORIGINAL INVESTIGATION Use of Complementary and Alternative Medicines by Ambulatory Patients Susan M. Rhee, BS; Vinod K. Garg, MD; Charles O. Hershey, MD Background: Complementary and alternative medicines
More informationNutraStock PRODUCT LIST. Softgels + Tablets + Capsules. December 17, jdlabs.com Made in the USA
NutraStock PRODUCT LIST Softgels + Tablets + Capsules December 17, 2015 jdlabs.com 760.208.2292 Made in the USA JD3010 ACAI 500 MG SOFTGEL 10,000 JD3005 ACAI 1,500 MG SOFTGEL 8,000 JD3000 ACAI 1,000 MG
More informationOccupational therapy and complementary and alternative medicine
OCCUPATIONAL THERAPY INTERNATIONAL Published online in Wiley InterScience (www.interscience.wiley.com).268 Editorial Occupational therapy and complementary and alternative medicine EMILY HALTIWANGER AND
More informationDESCRIPTION PRODUCT CODE
Product List AIIKO Natturrall Oils Specialized Vegetable Oils Blackcurrant Oil Gamma Linolenic acid: 11.0-18.0% 101.001 Borage Oil Gamma Linolenic acid: 18.0-25.0% 101.002 Evening Primrose Oil (EPO) Gamma
More informationResearch Article The Use of Complementary and Alternative Medicine Supplements of Potential Concern during Breast Cancer Chemotherapy
Evidence-Based Complementary and Alternative Medicine Volume 2016, Article ID 4382687, 8 pages http://dx.doi.org/10.1155/2016/4382687 Research Article The Use of Complementary and Alternative Medicine
More informationKnowledge, Attitude and Practice of Complementary and Alternative Medicine (CAM) among Medical Practitioners
Original Reserch Paper Knowledge, Attitude and Practice of Complementary and Alternative Medicine (CAM) among Medical Practitioners Kong FH, Man LK, Shetty RS, Kamath VG ABSTRACT Background: Complementary
More informationSELF MEDICATION INTEGRATING COMPLEMENTARY MEDICINES WITH OTCS AND PRESCRIPTION MEDICINES
SELF MEDICATION INTEGRATING COMPLEMENTARY MEDICINES WITH OTCS AND PRESCRIPTION MEDICINES Dr Lesley Braun PhD Snr Research Fellow Dept Surgery, Monash University Research Pharmacist, Alfred Hospital, Melbourne
More informationRelationship between patient satisfaction with medical doctors and the use of traditional Korean medicine in Korea
Kim et al. BMC Complementary and Alternative Medicine DOI 10.1186/s12906-015-0879-x RESEARCH ARTICLE Open Access Relationship between patient satisfaction with medical doctors and the use of traditional
More informationRegulating the Unregulated: Talking to Patients About Use of Dietary Supplements
Regulating the Unregulated: Talking to Patients About Use of Dietary Supplements Kristina Thurber, Pharm.D., BCPS Internal Medicine Clinical Pharmacist Mayo Clinic Hospital Rochester Pharmacy Grand Rounds
More informationGreen Atom Ingredients PRODUC T LIST Softgels + Tablets + Capsules
Green Atom Ingredients PRODUC T LIST 2017 Softgels + Tablets + Capsules GA3010 ACAI 500 MG SOFTGEL 10,000 GA3005 ACAI 1,500 MG SOFTGEL 8,000 GA3015 ALOE VERA GEL 5,000 MG SOFTGEL 12,000 GA3020 ALPHA LIPOIC
More informationHong Huang School of Information, University of South Florida, Tampa, FL, USA. ABSTRACT
SOCIOECONOMIC STATUS, ATTITUDES ON USE OF HEALTH INFORMATION, PREVENTIVE BEHAVIORS, AND COMPLEMENTARY AND ALTERNATIVE MEDICAL THERAPIES: USING A U.S. NATIONAL REPRESENTATIVE SAMPLE Yiu Ming Chan Department
More informationExplanatory Attributions of Anxiety and Recovery in a Study of Kava
THE JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE Volume 10, Number 3, 2004, pp. 556 559 Mary Ann Liebert, Inc. Explanatory Attributions of Anxiety and Recovery in a Study of Kava KURIAN C. ABRAHAM,
More informationKNOWLEDGE OF SAFETY AND HERB-DRUG INTERACTIONS AMONGST HIV+ INDIVIDUALS: A FOCUS GROUP STUDY
KNOWLEDGE OF SAFETY AND HERB-DRUG INTERACTIONS AMONGST HIV+ INDIVIDUALS: A FOCUS GROUP STUDY Blair Leonard, 1 Hal Huff, 2 Bill Merryweather, 3 Aileen Lim, 3 Edward Mills 2,4 1 Department of Medicine, University
More informationDevelopment of a Supplement Composition Database for the SURE Study. Kim Yonemori,, Suzanne Murphy, Yukiko Morimoto, Lynne Wilkens
Development of a Supplement Composition Database for the SURE Study Kim Yonemori,, Suzanne Murphy, Yukiko Morimoto, Lynne Wilkens Overview The SURE Study The Cancer Research Center of Hawaii s dietary
More informationEnriched Skin Care Products
UPC CODE LIST QTY COST SUGTD 0-79854 NO. ORD SIZE DESCRIPTION EACH RETAIL VITAMINS A AND D 10005-1 110 100 Vitamin A 8000 IU Softgel $2.26 $3.79 10011-2 1103 100 Beta Carotene 25,000 IU Softgel $4.64 $7.79
More informationVITAMIN SURVEY FORM CODE: VIT Version B
ARIC MRI VITAMIN SURVEY FORM CODE: VIT Version B ID Number: Contact Year: 16 Instructions: Whenever numerical responses are required, enter the number so that the last digit appears in the rightmost box.
More informationDietary Supplement Questionnaire
Dietary Supplement Questionnaire Please ensure you sign the consent form prior to completing this questionnaire. Athlete Name: Age: Date of Birth: Gender: M / F Weight: Height: Competitive Sport: Classification:
More informationThe Relationship Between Cancer-Related Fatigue and Patient Satisfaction with Quality of Life in Cancer
40 Journal of Pain and Symptom Management Vol. 34 No. 1 July 2007 Original Article The Relationship Between Cancer-Related Fatigue and Patient Satisfaction with Quality of Life in Cancer Digant Gupta,
More informationHerbal Facts and Fallacies
Herbal Facts and Fallacies Geneva Briggs, Pharm.D., BCPS MedOutcomes, Inc. This program has been brought to you by PharmCon PharmCon is accredited by the Accreditation Council for Pharmacy Education as
More informationHORMONE BALANCE QUESTIONNAIRE FOR MEN
HORMONE BALANCE QUESTIONNAIRE FOR MEN Name: Date: Address: City: State: Zip: Home Phone: Cell Phone: Work Phone: Date of Birth: Age: Height: Weight: Primary Care Doctor: Health History Do you have a personal
More informationComparison of Two Instruments for Quantifying Intake of Vitamin and Mineral Supplements: A Brief Questionnaire versus Three 24-Hour Recalls
American Journal of Epidemiology Copyright 2002 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 156, No. 7 Printed in U.S.A. DOI: 10.1093/aje/kwf097 Comparison of Two Instruments
More informationWhy do patients take herbs and nutritional supplements?
Why do patients take herbs and nutritional supplements? Dissatisfaction with conventional medicine > Relieve cancer-related symptoms > Treat adverse effects of anticancer drugs > Treat cancer > Promote
More informationComplementary and alternative medicine (CAM) is
original research UTILIZATION, PATIENT SATISFACTION, AND COST IMPLICATIONS OF ACUPUNCTURE, MASSAGE, AND NATUROPATHIC MEDICINE OFFERED AS COVERED HEALTH BENEFITS: A COMPARISON OF TWO DELIVERY MODELS Darrell
More informationCurriculum Planning: A Needs Assessment for Complementary and Alternative Medicine Education in Residency
190 March 2007 Family Medicine Curriculum Planning: A Needs Assessment for Complementary and Alternative Medicine Education in Residency Sarita H. Prajapati, MD, MPH; Ronald F. Kahn, MD; Tracy Stecker,
More informationNutraStock PRODUCT PRICING LIST. Softgels + Tablets + Capsules. July 1, jdlabs.com Made in the USA
NutraStock PRODUCT PRICING LIST Softgels + Tablets + Capsules July 1, 2016 jdlabs.com 760.208.2292 Made in the USA JD1000 5-HTP 100 MG CAPSULE 20,000 $45.55 JD3010 ACAI 500 MG SOFTGEL 10,000 $29.60 JD3005
More informationChanges in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study
Greenlee et al. BMC Cancer 2014, 14:382 RESEARCH ARTICLE Open Access Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study Heather
More informationBMC Complementary and Alternative Medicine 2010, 10:35
BMC Complementary and Alternative Medicine This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon.
More informationWhat is the menopause?
Information for you Alternatives to hormone replacement therapy for symptoms of the menopause Published in December 2011 This information is for you if you are considering alternatives to hormone replacement
More informationUse of Complementary Medicine in Older Americans: Results From the Health and Retirement Study
The Gerontologist Vol. 45, No. 4, 516 524 Copyright 2005 by The Gerontological Society of America Use of Complementary Medicine in Older Americans: Results From the Health and Retirement Study Jose Ness,
More informationComplementary & Integrative Cancer Care Clinician Scientist s View from a Naturopathic Doctor
Complementary & Integrative Cancer Care Clinician Scientist s View from a Naturopathic Doctor Dugald Seely, ND, MSc, FABNO Founder & Executive Director; OICC Director; Research & Clinical Epidemiology;
More informationAn Approach to Assessing Dietary Supplement Intake for use in Conjunction with the Collection of 24- hour Dietary Recalls
An Approach to Assessing Dietary Supplement Intake for use in Conjunction with the Collection of 24- hour Dietary Recalls Lisa Harnack, DrPH, RD Assistant Director Nutrition Coordinating Center Division
More informationMEDICATIONS IN DISEASE TREATMENT. Diet, Medications, and Dietary Supplements. Over-the-Counter Drugs. Prescription Medications.
Diet, Medications, and Dietary Supplements Chapter 19 MEDICATIONS IN DISEASE TREATMENT Prescription Medications Usually given to treat serious conditions May cause side effects Physician evaluates the
More informationThe CAMELOT study: Complementary therapy use among people with type 2 diabetes or CVD
Rachel Canaway, Lenore Manderson, Vivian Lin The CAMELOT study: Complementary therapy use among people with type 2 diabetes or CVD 3 October 2012 www.camelot.monash.edu Care seeking, use of complementary
More informationIntegrating Foods and Dietary Supplements into a Single Composition Table
Integrating Foods and Dietary Supplements into a Single Composition Table Donna Lyn Au, MPH, RD Carrie Blitz, RD Kim Murakami, RD Suzanne Murphy, PhD, RD Yun Oh Jung Maj Earle Overview Cancer Research
More informationParental Attitudes toward Human Papilloma Virus Vaccine Participation of Adolescent Daughters in a Rural Population
Diversity and Equality in Health and Care (2018) 15(4): 164-168 2018 Insight Medical Publishing Group Research Article Parental Attitudes toward Human Papilloma Virus Vaccine Participation of Adolescent
More informationLIFESTYLE MANAGEMENT
DIETARY SUPPLEMENTS LIFESTYLE MANAGEMENT NUTRITION FOR MEN WITH PROSTATE CANCER POWER SNACK BALLS Serves. Ready in 20 min. Inactive time 1h. Recipe credit: www.nourishonline.ca Nutrition Facts Serving
More informationClinical Considerations of Herbal Product Utilization within the Oncology Patient Population. Jessica Unzaga, PharmD, BCPS, BCOP FLASCO Fall Session
Clinical Considerations of Herbal Product Utilization within the Oncology Patient Population Jessica Unzaga, PharmD, BCPS, BCOP FLASCO Fall Session Disclosures I have no conflicts of interest Off-label
More informationINTRODUCTORY SUPPLEMENT GUIDE
INTRODUCTORY SUPPLEMENT GUIDE THE TOP 12 SUPPLEMENTS TO CONSIDER USING: Whey Protein Isolate Creatine Monohydrate Standard Multivitamin Omega 3 Fatty Acid (EPA/DHA) Branched Chain Amino Acids (BCAAs) Vitamin
More informationMINIMUM ADVERTISED PRICE AND INTERNET RESELLING POLICY. Updated March 26, 2018
MINIMUM ADVERTISED PRICE MINIMUM ADVERTISED PRICE AND INTERNET RESELLING POLICY Updated March 26, 2018 Gaia Herbs, Inc., (Gaia) has unilaterally adopted this Minimum Advertised Price Policy (MAP Policy),
More informationThe use of dietary supplements and their association with blood pressure in a large Midwestern cohort
McCarty et al. BMC Complementary and Alternative Medicine 2013, 13:339 RESEARCH ARTICLE The use of dietary supplements and their association with blood pressure in a large Midwestern cohort Catherine A
More informationBMC Public Health. Open Access. Abstract. BioMed Central
BMC Public Health BioMed Central Research article Prevalence of nonvitamin, nonmineral supplement usage among students in a Turkish university Unal Ayranci* 1, Nazan Son 2 and Osman Son 3 Open Access Address:
More informationJournal of Complementary and Integrative Medicine
Journal of Complementary and Integrative Medicine Volume 4, Issue 1 2007 Article 11 Using the Behavioral Model for Complementary and Alternative Medicine: The CAM Healthcare Model Judith M. Fouladbakhsh
More informationThe Use of Herbal Medications and Dietary Supplements by People with Mental Illness
Community Ment Health J (2010) 46:563 569 DOI 10.1007/s10597-009-9235-2 BRIEF REPORT The Use of Herbal Medications and Dietary Supplements by People with Mental Illness Noosha Niv Æ Jess P. Shatkin Æ Alison
More informationA systematic literature review on biologically based CAM-practices for cancer patients
A systematic literature review on biologically based CAM-practices for cancer patients Christine Paludan-Müller, PhD, The Danish Cancer Society Anita Lunde, Scientific Assistant, cand.cur., The University
More informationCE on SUNDAY Jacksonville, FL May 3, 2009
CE on SUNDAY Jacksonville, FL May 3, 2009 Date: Sunday, May 3, 2009 Time: 12:15 PM 1:15 PM Location: Hyatt Regency Jacksonville Riverfront Hotel Title: Speaker(s): Herbal Facts and Fallacies ACPE # 798-000-09-020-L01-P
More informationTilburg University Increased health care utilisation among 10-year breast cancer survivors General rights Take down policy
Tilburg University Increased health care utilisation among 10-year breast cancer survivors van de Poll-Franse, L.V.; Mols, Floortje; Vingerhoets, Ad; Voogd, A.C.; Roumen, R.M.H.; Coebergh, J.W.W. Published
More informationPharmacy Students Knowledge and Attitude towards Herbal Medications
Pharmacy Students Knowledge and Attitude towards Herbal Medications Sneha Sura, Amrita Chabria, Sujit S. Sansgiry, College of Pharmacy, University of Houston, Houston, TX Research Article Please cite this
More informationP HC. There is a growing interest in the use of complementary and alternative. The Use of. Complementary and. Alternative
ORIGINAL ARTICLE P HC Complementary and The Use of Alternative ABSTRACT Introduction: The purposes of this descriptive study were to: (a) describe the use of complementary and alternative medicine (CAM)
More informationProgress in Development of the Dietary Supplement Ingredient Database
Progress in Development of the Dietary Supplement Ingredient Database JT Dwyer, MF Picciano, JM Betz, K Fisher, LG Saldanha, EA Yetley & PM Coates, ODS NIH; K Radimer, & B Bindewald, NHANES/NCHS; K Sharpless,,
More informationFrequency of Use of Complementary and Alternative Medicine in Women with Breast Cancer
Western Kentucky University TopSCHOLAR Nursing Faculty Publications School of Nursing 20 Frequency of Use of Complementary and Alternative Medicine in Women with Breast Cancer Cecile A. Lengacher Mary
More informationCRACIUN RESEARCH. Alaska Injury Prevention Center CHA. September 7, 2014
CRACIUN RESEARCH CHA A M A R K E T R E S E A R C H S T U D Y Alaska Injury Prevention Center September 7, 2014 Craciun Research Anchorage. Seattle. Washington, DC 206.708.4500 www.craciunresearch.com 2014
More informationFrequent Use of Complementary Medicine by Prostate Cancer Patients
European Urology European Urology 43 (2003) 604 608 Frequent Use of Complementary Medicine by Prostate Cancer Patients Anton Ponholzer a,b, Gerhard Struhal c, Stephan Madersbacher a,b,* a Department of
More informationHerbal/Drug Interactions. Gary W. Elmer 11/12/09
Herbal/Drug Interactions Gary W. Elmer 11/12/09 Elmer et al. Ann Pharmacother. 2007;40:1617-24. Table 4a Significant Risk of CAM-drug Adverse Interaction n=5052 (16,173 interviews) Potential Event Mechanism
More informationBMC Complementary and Alternative Medicine
BMC Complementary and Alternative Medicine BioMed Central Research article Complementary and alternative medical therapy utilization by people with chronic fatiguing illnesses in the United States James
More informationPatient Satisfaction with Quality of Life as a Predictor of Survival in Pancreatic Cancer
International Journal of Gastrointestinal Cancer, vol. 37, no. 1, 035-043, 2006 Copyright 2006 by Humana Press Inc. All rights of any nature whatsoever reserved. 0169-4197/06/37:35 43/$30.00 Research Article
More informationGSCI 2202 FOOD FOR HEALTH. Eat to compete: Dietary Supplements
GSCI 2202 FOOD FOR HEALTH Eat to compete: Dietary Supplements Dietary supplements on the market are: NOT regulated Could contain illegal substances Could be costly Could be harmful Current laws on dietary
More informationDepartment of Preventive Medicine and Public Health 3 University of Kansas School of Medicine-Kansas City
Prevalence and Predictors of Social Support Utilization among Cancer Patients Undergoing Treatment John Hunninghake, M.D. 1, Fanglong Dong, Ph.D. 2, Robert B. Hines, Ph.D. 2, Elizabeth Ablah, Ph.D. 2,
More informationKnowledge and Practice of Complementary Medicine Amongst Public Primary Care Clinic Doctors in Kinta District, Perak
Knowledge and Practice of Complementary Medicine Amongst Public Primary Care Clinic Doctors in Kinta District, Perak I A Ismail, MBChB*, S C Chan, FRACGP** *Hospital Ipoh, Perak, **Department of Primary
More informationCancer Survivors: - Asian Perspective
Cancer Survivors: What we Know, What we Need to Know - Asian Perspective Prof. Josette Sin-yee Chor School of Public Health and Primary Care The Chinese University of Hong Kong Asia Varying incidence of
More informationMOKP COST CONTAINMENT GRANT FINAL REPORT
MOKP COST CONTAINMENT GRANT FINAL REPORT Project Title: Helping Recipients Ask: The Effectiveness of Improved Health Education on Increasing Living Donation. Applicant Name: Amy D. Waterman, PhD Address:
More informationMedicinal Chemistry 525 (2 credits)
Medicinal Chemistry 525 (2 credits) Alternative and Complementary Medicines Thursdays 1:30-3:20 Room T747 http://courses.washington.edu/medch420/ Gary Elmer, H172j Health Sciences, 543-2055, elmer@u.washington.edu
More informationAndrogen deprivation therapy for treatment of localized prostate cancer and risk of
Androgen deprivation therapy for treatment of localized prostate cancer and risk of second primary malignancies Lauren P. Wallner, Renyi Wang, Steven J. Jacobsen, Reina Haque Department of Research and
More informationINTEGRATIVE MEDICINE IN AMERICA
INTEGRATIVE MEDICINE IN AMERICA How Integrative Medicine Is Being Practiced in Clinical Centers Across the United States FEBRUARY 2012 Bonnie Horrigan Sheldon Lewis Donald Abrams, MD Constance Pechura,
More informationExternal Qigong Therapy for Chronic Orofacial Pain
External Qigong Therapy for Chronic Orofacial Pain A Letter to the Editor Journal of Alternative and Complementary Medicine, 2002, 8(5): 532-534. Dear Editor, We would like to share the results of an anecdotal
More informationKEE HING CHEUNG KEE CO., LTD. DLFTZ CHANG HING KEE INT L INDUSTRY & TRADE CO., LTD.
KEE HING CHEUNG KEE CO., LTD. DLFTZ CHANG HING KEE INT L INDUSTRY & TRADE CO., LTD. OEM healthy food Soft Capsules 1 Aloe Vera 1000mg Aloe powder, Beeswax,, shortening 2 American ginseng Panaquilon, shortening,
More informationWashington State Department of Agriculture Organic Program
Washington State Department of Agriculture Organic Program In accordance with USDA Organic Regulations - Title 7 CFR Part 205, National Organic Program - this Organic Certificate is issued to 1304 Meador
More informationComplementary & Alternative Medicine. Integrative Therapies:
Complementary & Alternative Medicine Integrative Therapies: By: Melanie Santos RNIII, BSN, OCN, CMSRN Salinas Valley Memorial Healthcare System Five Branches University Student : March 2019 WHAT IS CAM?
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association Inpatients use, understanding, and attitudes towards traditional, complementary and alternative therapies at a provincial
More informationComplementary Therapies (CTs): THE EMPEROR S NEW CLOTHES?
Complementary Therapies (CTs): THE EMPEROR S NEW CLOTHES? Edzard Ernst, Emeritus Professor, Uni Exeter PC2-2012 Cancer v1-1 The Emperor's New Clothes (1837) Two crooks promise the emperor new clothes which,
More informationnationalvitamincompany
Vitamins Minerals Herbals OTC Products Nutritional Supplements Enriched Skin Care Products Catalog Number 26 Prices Effective March 2016 nationalvitamincompany 100% Owned and Operated in the USA Nature
More informationNo Nutraceuticals Form Packing 1 Special C 500 Tablets 60's 2 Jointflex Tablets 44's 3 Glucosamine and Condroitin Tablets 30's 4 Iron 65 mg Tablets
No Nutraceuticals Form Packing 1 Special C 500 Tablets 60's 2 Jointflex Tablets 44's 3 Glucosamine and Condroitin Tablets 30's 4 Iron 65 mg Tablets 90's 5 Selenium Capsules 60's 6 Zinc 50 mg Tablets 60's
More informationFort Garry Campus, University of Manitoba
Dementia Conference Medication Information Line Meera B. Thadani, MSc(Pharm) M.Sc.(Pharm.) Outreach Pharmacist March 2014 1 MILE Medication Information Line for Everyone 2 1 Located at the U of M Fort
More informationSocial Issues in Nonmetropolitan Nebraska: Perceptions of Social Stigma and Drug and Alcohol Abuse: 2018 Nebraska Rural Poll Results
University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Publications of the Rural Futures Institute Rural Futures Institute at the University of Nebraska 8-2-2018 Social Issues
More informationCenter for Natural Healing Price List of Gaia Herbs Products April 2018
Order: 1-800-757-9731 Center for Natural Healing Price List of Gaia Herbs Products April 2018 Capsules & Tablets prices subject to change without notice A57060 Adrenal Health Daily Support 60 caps Stress
More informationThe Center For Healthy Living & Longevity Keri Topouzian, D.O. Fax:
The Center For Healthy Living & Longevity Keri Topouzian, D.O. Fax: 248.792.0345 Pediatric Health Questionnaire Today s Date: / / BLOOD TYPE: Patient Name: Birth date: / / Age: Mother s Name Father s Name
More informationAIDS and HIV Support. Lancet 1994;343: Humphrey JH, Quinn T, Fine D, et al. Short-term effects of large-dose vitamin A
AIDS and HIV Support Acquired immunodeficiency syndrome (AIDS) is a condition in which the immune system becomes severely weakened and loses its ability to fight infections. Most scientists believe that
More informationPrimary Care Physicians Attitudes and Practices Regarding Complementary and Alternative Medicine
Primary Care Physicians Attitudes and Practices Regarding Complementary and Alternative Medicine Margot E. Kurtz, PhD Robert B. Nolan, DC, DO William J. Rittinger, DO Data were gathered from 423 osteopathic
More information